| scholarly article | Q13442814 |
| P50 | author | Beatrice Schuler-Thurner | Q92348405 |
| Matteo Ramazzotti | Q38328011 | ||
| Inge Marie Svane | Q39271516 | ||
| Duccio Cavalieri | Q42698095 | ||
| Irene Stefanini | Q56855044 | ||
| Stefanie Gross | Q56856922 | ||
| P2093 | author name string | Sonja I Buschow | |
| Carl G Figdor | |||
| Jiannis Ragoussis | |||
| Harm Westdorp | |||
| Gerold Schuler | |||
| Dilair Baban | |||
| Luca Beltrame | |||
| Eva Ellebaek | |||
| Stanleyson V Hato | |||
| Jonathan M Austyn | |||
| Nikolaus Romani | |||
| Van Anh Nguyen | |||
| Lucie M Heinzerling | |||
| Georg Weinlich | |||
| I Jolanda M De Vries | |||
| Inge M J Reinieren-Beeren | |||
| P2860 | cites work | Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used | Q58619928 |
| Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients | Q58619940 | ||
| Immunomonitoring Tumor-Specific T Cells in Delayed-Type Hypersensitivity Skin Biopsies After Dendritic Cell Vaccination Correlates With Clinical Outcome | Q58620035 | ||
| Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial | Q60634928 | ||
| S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma | Q73181527 | ||
| Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells | Q74280070 | ||
| Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome | Q81286559 | ||
| Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma | Q86229575 | ||
| Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes | Q24534395 | ||
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation | Q24548297 | ||
| Significance analysis of microarrays applied to the ionizing radiation response | Q24606608 | ||
| Oncolytic virus therapy: A new era of cancer treatment at dawn | Q26739714 | ||
| Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards | Q26744395 | ||
| Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the Fate | Q26777205 | ||
| Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy | Q26798404 | ||
| CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients | Q27692628 | ||
| Improving cancer immunotherapy by targeting the STATe of MDSCs | Q28066797 | ||
| Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy | Q28080262 | ||
| Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP | Q28144497 | ||
| Visualisation of BioPAX Networks using BioLayout Express (3D) | Q28649340 | ||
| PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes | Q29547229 | ||
| Final version of 2009 AJCC melanoma staging and classification | Q29614803 | ||
| lumi: a pipeline for processing Illumina microarray | Q29614924 | ||
| STRING v10: protein-protein interaction networks, integrated over the tree of life | Q29615545 | ||
| Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients | Q34250873 | ||
| Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy | Q34522172 | ||
| Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma | Q35078852 | ||
| Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment | Q35227986 | ||
| Gene-expression profiling in vaccine therapy and immunotherapy for cancer | Q36138329 | ||
| Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling | Q36140818 | ||
| Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma | Q36375683 | ||
| The tumour microenvironment and implications for cancer immunotherapy | Q36521830 | ||
| MDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer | Q36782579 | ||
| RKIP contributes to IFN-γ synthesis by CD8+ T cells after serial TCR triggering in systemic inflammatory response syndrome | Q36986264 | ||
| Dendritic cell vaccination and immune monitoring. | Q37212802 | ||
| Mutation landscape in melanoma patients clinical implications of heterogeneity of BRAF mutations | Q37352562 | ||
| integrOmics: an R package to unravel relationships between two omics datasets | Q37432352 | ||
| Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma | Q37611006 | ||
| Molecular signatures of antibody responses derived from a systems biology study of five human vaccines | Q37625332 | ||
| Gene signature in melanoma associated with clinical activity: a potential clue to unlock cancer immunotherapy | Q37778702 | ||
| Profile of ipilimumab and its role in the treatment of metastatic melanoma | Q37977920 | ||
| RKIP: much more than Raf kinase inhibitory protein | Q38077517 | ||
| Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer | Q38173798 | ||
| Signaling pathways involved in MDSC regulation | Q38204175 | ||
| Interactions of RKIP with inflammatory signaling pathways | Q38322294 | ||
| Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential | Q38414485 | ||
| Dendritic Cell-Based Immunotherapy: State of the Art and Beyond. | Q38809786 | ||
| Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients | Q38944200 | ||
| Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells | Q39584588 | ||
| Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab | Q40506025 | ||
| Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. | Q40529472 | ||
| Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab | Q40758666 | ||
| Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses | Q40802250 | ||
| Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab | Q41469907 | ||
| Predictive immune markers in advanced melanoma patients treated with ipilimumab | Q42427603 | ||
| Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial | Q43080246 | ||
| International trends in the incidence of malignant melanoma 1953-2008--are recent generations at higher or lower risk? | Q43604521 | ||
| Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer | Q44670943 | ||
| Utility of the housekeeping genes 18S rRNA, beta-actin and glyceraldehyde-3-phosphate-dehydrogenase for normalization in real-time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes | Q44925185 | ||
| Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination | Q46885041 | ||
| Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines. | Q50669894 | ||
| Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy. | Q50954469 | ||
| EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC). | Q51694711 | ||
| The role of Raf kinase inhibitor protein in rheumatoid fibroblast-like synoviocytes invasiveness and cytokine and matrix metalloproteinase expression. | Q54591208 | ||
| Validation of housekeeping genes for normalizing RNA expression in real-time PCR. | Q54708147 | ||
| Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients | Q56637518 | ||
| Clinical application of circulating tumor cells in breast cancer | Q57129057 | ||
| Skin-Test Infiltrating Lymphocytes Early Predict Clinical Outcome of Dendritic Cell-Based Vaccination in Metastatic Melanoma | Q58619897 | ||
| P433 | issue | 40 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| metastatic melanoma | Q18975855 | ||
| P304 | page(s) | 67439-67456 | |
| P577 | publication date | 2017-06-27 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein | |
| P478 | volume | 8 |
| Q89978064 | Blood Eosinophilia is an on-Treatment Biomarker in Patients with Solid Tumors Undergoing Dendritic Cell Vaccination with Autologous Tumor-RNA |
| Q93018018 | Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment |
| Q58704356 | RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact |
Search more.